Literature DB >> 7085919

Comparison of lymphocyte transformation and macrophage migration inhibition tests in the detection of beryllium hypersensitivity.

W R Williams, W J Williams.   

Abstract

In seven patients with chronic beryllium disease (Be) the Be lymphocyte transformation test was positive in 100%, independent of steroid therapy, and was reproducible. The Be macrophage migration inhibition test was only positive in four of seven patients (57%) not on steroids, and was not reproducible. In 72 potentially exposed healthy beryllium workers the lymphocyte transformation test was negative in all subjects. The macrophage test was positive in four of 78 and again the results were not reproducible. The workers with positive results showed no differences in age, type or duration of employment from those with negative results and showed no evidence of disease. In addition, the macrophage test was positive in two of 45 non-exposed control subjects. We also confirmed the above advantages of the lymphocyte transformation technique by using tuberculin antigen (PPD). The PPD lymphocyte transformation test gave positive results in approximately 60% of healthy beryllium workers, but the PPD macrophage test was only positive in 7%. We conclude that the Be lymphocyte transformation test is the most sensitive and reproducible and advocate its use in the diagnosis of disease and in monitoring the health of potentially exposed workers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085919      PMCID: PMC497750          DOI: 10.1136/jcp.35.6.684

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Beryllium disease--pathology and diagnosis.

Authors:  W J Williams
Journal:  J Soc Occup Med       Date:  1977-07

2.  Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer.

Authors:  D E Bice; M Lopez; H Rothschild; J Salvaggio
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

3.  Delayed hypersensitivity to beryllium compounds.

Authors:  J J Marx; R Burrell
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

4.  A study of the immunologic aspects of chronic berylliosis.

Authors:  S D Deodhar; B Barna; H S Van Ordstrand
Journal:  Chest       Date:  1973-03       Impact factor: 9.410

5.  Diagnosis of chronic beryllium disease.

Authors:  W J Williams; J Grey; E Pioli
Journal:  Br Med J       Date:  1972-10-21

6.  In vitro demonstration of delayed hypersensitivity in patients with berylliosis.

Authors:  W R Henderson; K Fukuyama; W L Epstein; L E Spitler
Journal:  J Invest Dermatol       Date:  1972-01       Impact factor: 8.551

7.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

8.  In vitro studies on granulomatous hypersensitivity to beryllium.

Authors:  J M Hanifin; W L Epstein; M J Cline
Journal:  J Invest Dermatol       Date:  1970-10       Impact factor: 8.551

9.  Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.

Authors:  C D Price; W J Williams; A Pugh; D H Joynson
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

10.  Human macrophage migration inhibition factor: evidence for subunit structure.

Authors:  G Possanza; M C Cohen; T Yoshida; S Cohen
Journal:  Science       Date:  1979-07-20       Impact factor: 47.728

View more
  5 in total

1.  Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berylliosis: results from an experimental model.

Authors:  P Diot; A Le Pape; D Nolibe; G Normier; H Binz; J P Revillard; G Lasfargues; M Lavandier; E Lemarié
Journal:  Br J Ind Med       Date:  1992-05

2.  Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers.

Authors:  W J Williams; W R Williams
Journal:  Thorax       Date:  1983-01       Impact factor: 9.139

Review 3.  Significance of the blood beryllium lymphocyte proliferation test.

Authors:  L S Newman
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

4.  Stimulatory and cytotoxic effects of beryllium on proliferation of mouse spleen lymphocytes in vitro.

Authors:  R J Price; D N Skilleter
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

5.  Chronic beryllium disease: uncommon disease, less common diagnosis.

Authors:  D C Middleton
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.